Dr. Shannon Maclaughlan, MD
- Medicare services, 2024
- 90
- Medicare patients, 2024
- 46
- Part D claims, 2024
- 80
- Publications
- 9
- Clinical trials
- 5
- Practice address
- 5721 S Maryland Ave, Chicago, IL 60637
- Practice phone
- Call (773) 702-1530
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Comer Children's Hospital - Hyde Park
Chicago, Illinois
Find Dr. Maclaughlan's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Shannon Maclaughlan is a gynecologic oncologist in Chicago, Illinois
Dr. Maclaughlan practices at Comer Children's Hospital - Hyde Park in Chicago, Illinois.
Dr. Maclaughlan's NPI, 1720001894, was assigned on July 26, 2006. Dr. Maclaughlan graduated from University of Florida College of Medicine in 2002. Dr. Maclaughlan holds Illinois license 036148061.
- NPI
- 1720001894NPI Registry (opens in a new tab)
- NPI enumeration date
- July 26, 2006
- NPI status
- Active
- Practice phone
- (773) 702-1530
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 50
- Medical school graduation
- 2002
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Practice Data
Dr. Shannon Maclaughlan practices at Comer Children's Hospital - Hyde Park in Chicago, Illinois
Dr. Maclaughlan's primary practice is Comer Children's Hospital - Hyde Park, at 5721 S Maryland Ave, Chicago, IL 60637 in Cook County. The practice phone is (773) 702-1530.
- Comer Children's Hospital - Hyde Park5721 S Maryland Ave, Chicago, IL 60637 · Cook CountyPhone(773) 702-1530
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Shannon Maclaughlan is affiliated with 2 sites of care and 1 medical group
Dr. Maclaughlan's primary practice is Comer Children's Hospital - Hyde Park in Chicago, Illinois. The medical group on file is University of Illinois Physicians Group (UIPG). Dmand AI also links Dr. Maclaughlan to 1 more group practice or clinic, named with a free account.
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Shannon Maclaughlan's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Maclaughlan practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Comer Children's Hospital - Hyde Park | Available with a free account |
| +1 more affiliated site | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Shannon Maclaughlan is one of 70 gynecologic oncologists in Illinois
Gynecologic oncology is Dr. Maclaughlan's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dmand AI has Dr. Maclaughlan's licenses on file in 3 states: Illinois, California and Rhode Island.
Specialties and state licenses
- Gynecologic oncology, IllinoisPrimary
- California license
- Obstetrics and gynecology, Rhode Island
Gynecologic oncologists near Dr. Maclaughlan
Counts of gynecologic oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Shannon Maclaughlan billed Medicare for 90 services in 2024
CMS data shows 90 Medicare services from Dr. Maclaughlan across 2 procedure codes in 2024, all of them office visits, for 46 Medicare patients. Medicare paid $6,254 for them. Every service was in a facility, such as a hospital, rather than an office.
Dr. Maclaughlan's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 1052024: 9014%
Dr. Maclaughlan compared with the Illinois median for gynecologic oncologists, 2024
- Dr. Maclaughlan
- Illinois median
- Medicare services
- 90vs 21258% below
- Medicare patients
- 46vs 13265% below
- Part D claims
- 12vs 3465% below
Medians across 71 gynecologic oncologists in Illinois with Dmand AI profiles that report each measure.
Dr. Maclaughlan's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Maclaughlan?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Maclaughlan and other gynecologic oncologists in Illinois.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Shannon Maclaughlan treated 46 Medicare patients in 2024, average age 70
CMS counts 46 Medicare patients who saw Dr. Maclaughlan in 2024. The largest group is 65 to 74, with 21 patients. 75% of them have high blood pressure, and 63% have cancer. 63% are also on Medicaid. Their average risk score is 1.95, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Maclaughlan's median patient age at 70, with 100% women.
Dr. Maclaughlan's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Chronic conditions among Dr. Maclaughlan's Medicare patients, 2024
- High blood pressure75%
- Cancer63%
- High cholesterol57%
- Arthritis41%
- Diabetes39%
- Mood disorders28%
- Depression26%
Share of Medicare patients with each condition. A patient can have several.
Dr. Maclaughlan's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 70
Patient panel by sex, all payers
- Women100%
- Men0%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Shannon Maclaughlan wrote 80 Medicare Part D claims in 2024
In 2024, Dr. Maclaughlan wrote 80 Medicare Part D claims for 22 patients. 75% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $105 in total drug cost. In 2023, CMS named 15 claims across 1 drug.
Dr. Maclaughlan's Part D claims by kind of drug, 2024
- Generic60 claims75%
- Brand-name20 claims25%
Dr. Maclaughlan's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Maclaughlan's Part D claims, 2024
- Opioids20%16 of 80 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 152024: 1220%
Drugs named by CMS: 1 in 2024, 1 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Shannon Maclaughlan scored 93 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Maclaughlan for performance year 2024, reported as part of a group.
Dr. Maclaughlan's MIPS scores, performance year 2024
- 93of 100Final score
- 73.5of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
- 71of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Source: Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Shannon Maclaughlan has 9 publications on record
Dmand AI links 9 papers to Dr. Maclaughlan, published from 2012 to 2023. 2013 was the busiest year, with 2. The most frequent topics are Ovarian Neoplasms. Dr. Maclaughlan's most frequent co-authors are Laurent Brard, MD, PhD, Alexander Brodsky, MD and Timothy C. Horan, Medical, Student.
Dr. Maclaughlan's papers by year, 2012 to 2023
Topics Dr. Maclaughlan writes about most
- Ovarian Neoplasms
Dr. Maclaughlan's most frequent co-authors
- Laurent Brard, MD, PhD3 shared papers
- Alexander Brodsky, MD2 shared papers
- Timothy C. Horan, Medical, Student2 shared papers
Recent publications by Dr. Maclaughlan
See who Dr. Maclaughlan researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Maclaughlan works with, so you can find a warm path to the right gynecologic oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Shannon Maclaughlan has worked on 5 clinical trials
Dmand AI links Dr. Maclaughlan to 5 clinical trials. 4 are still active or recruiting. Conditions studied include Fallopian Tube Diseases, Adenocarcinoma, Clear Cell and Carcinosarcoma. National Cancer Institute (NCI) sponsors the most, 2.
Clinical trials with Dr. Maclaughlan by phase
- 1Phase 1: 1 trial
- 1Phase 2: 1 trial
- 1Phase 2/3: 1 trial
- 1Phase 3: 1 trial
- NonePhase 4: no trials
Trials with no phase (devices, behavioral studies) are left out.
Conditions in Dr. Maclaughlan's trials
- Fallopian Tube Diseases
- Adenocarcinoma, Clear Cell
- Carcinosarcoma
- Ovarian Neoplasms
- Peritoneal Neoplasms
Investigators on the most trials with Dr. Maclaughlan
- Michael Ethan Carney, MD3 shared trials
- Natalie Shiralia Godbee, DO3 shared trials
- Cara A. Mathews, MD3 shared trials
Recent clinical trials with Dr. Maclaughlan
BrUOG 354: A Phase II Randomized Trial of Nivolumab +/- Ipilimumab for Ovarian and Extra-renal Clear Cell Carcinomas (opens in a new tab)
A Phase I Trial of Talimogene Laherparepvec for the Treatment of Peritoneal Surface Malignancies (opens in a new tab)
Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer (opens in a new tab)
Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Shannon Maclaughlan received $123 in industry payments from 2021 to 2024
CMS Open Payments shows 5 general payments to Dr. Maclaughlan from 3 drug and device companies from 2021 to 2024. Food and beverage make up the largest share, 100% of the total. GlaxoSmithKline, LLC. paid the most, $82.
General payments to Dr. Maclaughlan by program year, 2021 to 2024
Companies that paid Dr. Maclaughlan the most, 2021 to 2024
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Shannon Maclaughlan graduated from University of Florida College of Medicine
Dr. Maclaughlan graduated from University of Florida College of Medicine in 2002.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Shannon Maclaughlan's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Shannon Maclaughlan
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Shannon Maclaughlan's NPI number?
Dr. Shannon Maclaughlan's NPI number is 1720001894. It was assigned on July 26, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Shannon Maclaughlan?
Dr. Shannon Maclaughlan is a gynecologic oncologist in Chicago, Illinois. The primary specialty in the NPI Registry is Gynecologic Oncology Physician (taxonomy code 207VX0201X).
Where does Dr. Shannon Maclaughlan practice?
Dr. Maclaughlan practices at 5721 S Maryland Ave, Chicago, IL 60637. Dr. Maclaughlan's primary practice is Comer Children's Hospital - Hyde Park in Chicago, Illinois. Dmand AI also links Dr. Maclaughlan to 1 group practice or clinic.
What is Dr. Shannon Maclaughlan's office phone number?
The practice phone on file for Dr. Maclaughlan is (773) 702-1530.
What is Dr. Shannon Maclaughlan's medical license number?
Dr. Maclaughlan holds Illinois license 036148061, one of the licenses on file in 3 states.
Which states has Dr. Shannon Maclaughlan been licensed in?
Dmand AI has state licenses on file for Dr. Maclaughlan in Illinois, California and Rhode Island.
What medical group is Dr. Shannon Maclaughlan part of?
Dr. Maclaughlan is linked to University of Illinois Physicians Group (UIPG).
Does Dr. Shannon Maclaughlan accept Medicare?
Yes. CMS data shows Dr. Maclaughlan billed Medicare for 90 services in 2024.
What is Dr. Shannon Maclaughlan's MIPS score?
Dr. Maclaughlan's MIPS final score for performance year 2024 is 93 out of 100, reported as part of a group.
How many Medicare patients does Dr. Shannon Maclaughlan see?
CMS counts 46 Medicare patients who saw Dr. Maclaughlan in 2024, with an average age of 70.
Show 7 more questionsShow fewer questions
What services does Dr. Shannon Maclaughlan bill to Medicare?
In 2024, Dr. Maclaughlan's most billed Medicare services were office visit, established patient (99214) and office visit, established patient (99213).
Where did Dr. Shannon Maclaughlan go to medical school?
Dr. Maclaughlan graduated from University of Florida College of Medicine in 2002.
What drugs does Dr. Shannon Maclaughlan prescribe most?
In 2024 Medicare Part D data, Dr. Maclaughlan's most prescribed drugs by claims were Dexamethasone.
Has Dr. Shannon Maclaughlan received payments from drug or device companies?
CMS Open Payments shows $123 in general payments to Dr. Maclaughlan from 3 companies from 2021 to 2024. The largest total came from GlaxoSmithKline, LLC.
How long has Dr. Shannon Maclaughlan been practicing?
Dr. Maclaughlan graduated from medical school in 2002, 24 years ago.
Does Dr. Shannon Maclaughlan do research?
Dmand AI links 9 publications to Dr. Maclaughlan, published from 2012 to 2023. Dr. Maclaughlan has worked on 5 clinical trials.
Who does Dr. Shannon Maclaughlan publish with?
Dr. Maclaughlan's most frequent co-authors are Laurent Brard, MD, PhD (3 shared papers), Alexander Brodsky, MD (2 shared papers) and Timothy C. Horan, Medical, Student (2 shared papers).
Selling to gynecologic oncology practices?
See gynecologic oncologists in Illinois by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card